Business
Cardax Q1 2017 Revenues Triple vs. Prior Two Quarters Combined
Cardax Q1 2017 Revenues Triple vs. Prior Two Quarters Combined.
About this update from Cardax Inc
[{"type":"text","content":"\n \n Cardax, Inc. (“Cardax”) (OTCQB:CDXI) announced first quarter 2017 \n revenues from ZanthoSyn, the Company’s premium astaxanthin \n over-the-counter dietary supplement, were more than three times 2016 \n revenues, which began in August 2016. As previously reported, Cardax \n launched ZanthoSyn in General Nutrition Corporation’s (“GNC”) Hawaii \n stores in January 2017. (See the Company’s Quarterly Report on Form 10-Q \n for full results.)\n \n \n “We were very pleased to see accelerating sales this quarter driven by \n the ZanthoSyn product launch at GNC and strong physician acceptance,” \n commented Cardax CEO, David G. Watumull. “With the added momentum of our \n strong anti-aging study results, we are building a strong foundational \n business model for our future growth, not only in Hawaii but across the \n U.S. as well.”\n \n \n Quarterly highlights include:\n \n \n GNC ZanthoSyn Sales Accelerating. \n Sales of ZanthoSyn in Hawaii GNC stores accelerated throughout Q1 2017 \n following launch in January. Developing knowledgeable and motivated GNC \n store managers has been key to this growth. Cardax has initiated a \n successful outreach, training, and incentive program for these store \n managers. These efforts strongly align with GNC’s new business model \n focusing on solutions-based selling that combines products into \n “bundles” that effectively target their customers’ specific health needs.\n \n \n “Our in-depth interactions, including multiple store visits and \n educational seminars, provide the GNC store managers with a thorough \n understanding of the broad role ZanthoSyn can play at GNC and in the \n lives of their customers,” added Cardax Vice President, David M. \n Watumull, who leads the Company’s operations. “Given that ZanthoSyn can \n be utilized as a safe anti-inflammatory for joint, heart, liver, \n metabolic, brain, and athletic health, it can be a foundational product \n for virtually all GNC bundles.”\n \n \n Physician Acceptance. Cardax \n has conducted extensive educational meetings with more than 100 \n physicians, primarily in Hawaii. Many physicians are now employing \n ZanthoSyn as a safe anti-inflammatory for joint, cardiovascular, liver, \n metabolic, mental, and anti-agi...